Cargando…
Langerhans cell histiocytosis: current advances in molecular pathogenesis
Langerhans cell histiocytosis (LCH) is a rare and clinically heterogeneous hematological disease characterized by the accumulation of mononuclear phagocytes in various tissues and organs. LCH is often characterized by activating mutations of the mitogen-activated protein kinase (MAPK) pathway with B...
Autores principales: | Sconocchia, Tommaso, Foßelteder, Johannes, Sconocchia, Giuseppe, Reinisch, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642229/ https://www.ncbi.nlm.nih.gov/pubmed/37965340 http://dx.doi.org/10.3389/fimmu.2023.1275085 |
Ejemplares similares
-
Regulation of the Immune System in Health and Disease by Members of the Bone Morphogenetic Protein Family
por: Sconocchia, Tommaso, et al.
Publicado: (2021) -
BRAF(V600E) promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis
por: Sconocchia, Tommaso, et al.
Publicado: (2023) -
Recent advances in the understanding of the molecular pathogenesis and targeted therapy options in Langerhans cell histiocytosis
por: Suh, Jin Kyung, et al.
Publicado: (2021) -
Role of p16 in the pathogenesis of Langerhans cell histiocytosis
por: Kim, Sun-Young, et al.
Publicado: (2010) -
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
por: Caratelli, Sara, et al.
Publicado: (2017)